[Low molecular weight heparin in venous thromboembolism. Mechanism of action, therapy and prophylaxis].
作者信息
Stammler F, Diehm C
机构信息
Abteilung Innere Medizin/Angiologie, Klinikum Karlsbad-Langensteinbach.
出版信息
Dtsch Med Wochenschr. 1998 May 8;123(19):604-11. doi: 10.1055/s-2007-1024027.
PMID:9618643
Abstract
摘要
相似文献
1
[Low molecular weight heparin in venous thromboembolism. Mechanism of action, therapy and prophylaxis].[低分子量肝素在静脉血栓栓塞症中的应用。作用机制、治疗与预防]
Dtsch Med Wochenschr. 1998 May 8;123(19):604-11. doi: 10.1055/s-2007-1024027.
2
[Internal medicine therapy of venous thromboembolism].静脉血栓栓塞症的内科治疗
Ther Umsch. 1992 Dec;49(12):833-6.
3
Anticoagulant therapy for venous thromboembolism.
Prog Hemost Thromb. 1989;9:1-27.
4
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?静脉血栓栓塞症的治疗：普通肝素还是低分子量肝素？
Haematologica. 1995 Mar-Apr;80(2 Suppl):78-83.
5
[Use of heparin and oral anticoagulants to prevent and treat deep venous thrombosis and pulmonary embolism].[使用肝素和口服抗凝剂预防和治疗深静脉血栓形成及肺栓塞]
Arq Bras Cardiol. 1996 Sep;67(3):209-13.
6
Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.低分子量肝素：外科手术患者静脉血栓栓塞的预防
Semin Hematol. 1997 Oct;34(4 Suppl 4):9-19.
7
[Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].[低分子量肝素用于深静脉血栓形成。所有体重级别的剂量]
MMW Fortschr Med. 2003 Jun 12;145(24):56.
8
Management of venous thromboembolism.静脉血栓栓塞症的管理
N Engl J Med. 1996 Dec 12;335(24):1816-28. doi: 10.1056/NEJM199612123352407.
9
Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.静脉血栓栓塞性疾病的管理。低分子量肝素的影响。
Clin Chest Med. 1995 Jun;16(2):281-94.
10
Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism.低分子量肝素治疗急性静脉血栓栓塞症患者
Thromb Haemost. 1995 Jul;74(1):360-3.
Zotero 插件